A study by Wei-Jei Lee (Min-Sheng General Hospital, Taiwan) indicates that it is better to undergo metabolic surgery before 40 years. The patient can lose more weight and can get higher rates of type 2 diabetes (T2D) remission when age is less than 40 years compared with higher age. The study was published in JAMA.
Resistance to insulin and ability to move sugar into cells is the main cause of type 2 diabetes (T2D). The main reason for the buildup of insulin resistance is not known. The pancreas produces more insulin due to insulin resistance and blood contains high levels of insulin. High insulin levels affect fat metabolism and body gain more weight. Fat deposits block arteries because of diabetes. Blood sugar levels will be higher after eating due to resistance to insulin and high sugar levels damages blood vessels.
Dr. Kara Marlatt, a postdoctoral researcher at LSU's Pennington Biomedical Research Center think people living at higher altitude have a lower occurrence of diabetes and obesity. Researchers are using special tent and machine to simulate higher altitude. Participants are going to spend 14 nights sleep inside the tent to check improvement in the insulin sensitivity. Results could show new ways to control blood sugar levels.
Research shows that among type 2 diabetes (T2D) patients, a steep decline in the function of kidneys over time is associated with major cardiovascular events (MACE). Researchers studied estimated glomerular filtration rate (eGFR) over a period of time among 218 patients and concluded. The study was done by Stephanie Ragot, France.
Dr. Candice Hall , a California based doctor who believes diabetes can be reversed. She gave 4 step formula to prevent type 2 diabetes (T2D).
CVS Pharmacy became exclusive pharmacy for the American Diabetes Association. Both the organizations are going to raise awareness and funding for diabetes by featuring diabetes health and nutrition content. CVS Pharmacy store is going to display products and information to help people with diabetes disease under "Partner in Healthy Living" initiative.
MannKind Corporation collaborated with JDRF. With this collaboration, MannKind Corporation can utilize scientific and human resources of JDRF in the field of diabetes research and development. The MannKind organization is focusing to address the needs of people living with type 1 diabetes (T1D).
IBM Watson Health and the American Diabetes (ADA) are working together to identify, manage and prevent diabetes. IBM have previous experience in diabetes management and recently worked on ranking risk factors for diabetes in individual patients. Now the collaboration is going to develop tools that can help organizations in diabetes treatment.
A study led by Dr. William White (University of Connecticut School of Medicine, Farmington) found that an individual suffering from type 2 diabetes (T2D) and heart disease is more dangerous than previously thought. Type 2 diabetes (T2D) with the acute coronary syndrome (ACS) may lead to a major cardiac event and an individual needs more attention. Patients hospitalized with congestive heart failure may have 24 to 28 percent higher risk of death within 18 months. Both heart disease and type 2 diabetes (T2D) have obesity as a common risk factor. Study findings indicate heart may be impacted due to medications to control blood sugar. The findings of the study were published in the journal Diabetes Care.
Diabetes Technology Society (DTS) released DTSec standard designed for interconnected diabetes products. Some of them are
DTSec standard contains performance requirements to improve cybersecurity or IT security and DTSec uses ISO/IEC 15408 framework. Networked life-critical devices have to comply with the DTSec standard. Lead author of the standard was David Kleidermacher.
Dr. Raphael Kellman, an expert in thyroid disease, says millions of Americans were affected by hypothyroidism disease related to thyroid. Thyroid glands keep brain and heart work normally. American Thyroid Association estimates 12% of the Americans were affected. Dr. Minisha Sood, endocrinologist says there is a link between underperforming thyroid and diabetes. A study was conducted by Dr. Layal Chaker by tracking nearly 8,500 people over eight years. The study concluded that risk for diabetes increased by 13 percent due to the underperformance of thyroid glands. The study was published in a peer-reviewed medical journal.
Avita Medical Ltd started clinical trials to cure Diabetic Foot Ulcer (DFU) with ReGenerCell device at Manchester Royal Infirmary, UK. Diabetic Foot Ulcer (DFU) and Venous Leg Ulcers (VLU) are complications for diabetic patients and may lead to amputation of a leg. The first patient was enrolled for the clinical trial in UK and Avita Medical Ltd is planning to enroll up to 24 patients. 26 week evaluation period starts after clinical trial. ReGenerCell device enables the production of Regenerative Epithelial Suspension (RES) in 30 minutes by using a small sample of skin from the patient. The developed Regenerative Epithelial Suspension helps natural healthy skin development and healing.
M2D2 is a joint venture between University of Massachusetts Lowell and Worcester campuses. M2D2 is inviting open competition to identify and accelerate advancements in diabetes research and care in areas such as Devices, Diagnostics, Therapeutics and Technologies. The submission of competition papers is open till July 11, 2016. Winners will be with awarded (two) up to $150,000 in cash or services.
Study on the UK made meat substitute brand Quorn was published in British Journal of Nutrition. The findings indicate that Quorn component mycoprotein improves the functioning of pancreatic and reduces energy intake in obese people and prevents the development of type 2 diabetes (T2D) Mellitus and obesity. The study says that Quorn products are vegetarian meat replacements. Quorn component mycoprotein is high in protein and fiber.
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.